WSA
NEOS

Wall Street Associates’s Neos Therapeutics, Inc NEOS Stock Holding History

Wall Street Associates’s Portfolio NEOS Stock Details NEOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-149,343
Closed -$983K – 219
2016
Q3 		$983K Hold
149,343
– – 0.34% 104
2016
Q2 		$1.39M Hold
149,343
– – 0.55% 72
2016
Q1 		$1.61M Hold
149,343
– – 0.67% 59
2015
Q4 		$2.14M Sell
149,343
-50,000
-25% -$754K 0.6% 52
2015
Q3 		$4.19M Buy
+199,343
New +$4.39M 0.8% 34

Other funds holding NEOS

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
DA
DSC Advisors Chicago, Illinois $11M AUM 5.88% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

Wall Street Associates's NEOS Position: Q4 2016 in Review

Wall Street Associates sold out of Neos Therapeutics, Inc (NEOS) in Q4 2016, closing a stake of 149,343 shares — an estimated $983K sold.

Wall Street Associates first reported a position in NEOS in Q3 2015 and held it in 5 quarters. The position peaked at $4.19M in Q3 2015. 52 funds tracked by Wall St. Rank hold NEOS as of Q4 2016.

  • Wall Street Associates reported no remaining Neos Therapeutics, Inc position as of Q4 2016 after selling out during the quarter.
  • Wall Street Associates sold 149,343 Neos Therapeutics, Inc shares in Q4 2016, an estimated $983K.
  • Wall Street Associates first reported a position in Neos Therapeutics, Inc in Q3 2015 and held it in 5 quarters.
  • Wall Street Associates's Neos Therapeutics, Inc position peaked at $4.19M in Q3 2015.
  • 52 funds tracked by Wall St. Rank held Neos Therapeutics, Inc as of Q4 2016.

Based on Wall Street Associates's 13F filing for Q4 2016, filed 18 Jan 2017.